Home › Research › Topics › p-tau217
p-tau217
701 studies tagged p-tau217, dated 1989-01-01 to 2026-11-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Inflammatory biomarker candidates in dementia with Lewy bodies: diagnostic classification, clinical associations, and survival 2026-11-01
- Longitudinal plasma biomarkers and multimodal PET across APOE ε4 genotypes: a prospective cohort study 2026-11-01
- Concurrent cognitive, behavioral and systemic physiological features mark preclinical Alzheimer's disease 2026-10-30
Studies
701 studies carry this tag.
Date range
1989 to 2026
Top journals
- Alzheimer's & dementia : the journal of the Alzheimer's Association 123
- Journal of Alzheimer's disease : JAD 53
- Alzheimer's & dementia (Amsterdam, Netherlands) 46
- Alzheimer's research & therapy 36
- medRxiv 29
196 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Tau immunoreactivity was studied in temporal neocortex, area 22, in 15 cases with graded intellectual status and compared with the immunoreactivity observed with an antiserum against paired helical filaments (PHF) and with the density of amyloid revealed by thioflavin S. Samples came from women over 75 years either intellectually normal or affected by senile dementia of the Alzheimer type at various degrees of severity.
From across this tag
10 of the 699 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.
- Prognostic value of plasma %p-tau217 in cognitively unimpaired older adults
- Astrocyte reactivity is associated with tau tangle load and cortical thinning in Alzheimer's disease
- Blood-based circular RNAs for early diagnosis of Alzheimer's disease
- Plasma biomarkers predict Alzheimer's disease before clinical onset in Chinese cohorts
- Alzheimer's blood-based biomarkers, incident dementia, and interactions with age, APOE status, and hormone therapy
- Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease
- Developing novel blood-based biomarkers for Alzheimer's disease
- Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers
- Higher plasma β-synuclein indicates early synaptic degeneration in Alzheimer's disease
- Blood-based biomarkers for Alzheimer's disease: a multicenter-based cross-sectional and longitudinal study in China